Analyst / Investor Meet - Intimation
An Analyst /Investor Conference call to discuss on results for Q3FY2018 has been scheduled to be held on Monday January 22, 2018.16-01-2018
Analyst / Investor Meet - Intimation
An Analyst /Investor Conference call to discuss on results for Q3FY2018 has been scheduled to be held on Monday January 22, 2018.Notice Of Board Meeting On January 22, 2018
Notice is hereby given pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that the meeting of Board of Directors of the Company will be held on Monday, January 22, 2018 at the Registered Office of the Company, Vakrangee Corporate House, Plot No. 93, Road No.16, M.I.D.C. Marol, Andheri East, Mumbai - 400093, to inter alia, consider and approve Un-audited Financial Results for the quarter and nine...Statement Of Investor Complaints For The Quarter Ended December, 2017.
Pursuant to Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit statement of Investor Complaints for the quarter ended December 31, 2017.Press Release / Media Release
VAKRANGEE LIMITED ANNOUNCES ALLIANCE WITH NETMEDS MARKETPLACE LIMITED.Updates
Appointment of Mr. Rajesh Bhojwani as CEO - ATM and Mr. Harish Mani as CEO - Insurance.Shareholding for the Period Ended December 28, 2017
Vakrangee Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 28, 2017. For more details, kindly Click here